Diagnostic Performance of Non-Invasive Tests in Assessing Liver Fibrosis Among Type 2 Diabetes Mellitus.
FIB-4, APRI, and NFS are effective and affordable screening tools for initial fibrosis in patients with T2DM, particularly in low-resource settings and the combination of these measures may enhance the detection of at-risk individuals for referral and further management.